Clinical trial
Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With…
NCT00267176 · Novartis Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00267176 |
|---|---|
| Title | Safety and Efficacy of Lumiracoxib in Patients With Osteoarthritis and With Controlled Hypertension |
| Official title | A 4-week, Multicentre, Randomized, Double-blind, Double-dummy, Parallel Group Ambulatory Blood Pressure Monitoring Study to Investigate Whether Treatment With Lumiracoxib 100 mg Once Daily Results in an Improved 24-hour Blood Pressure Profile Compared to Ibuprofen 600 mg Three Times a Day in… |
| Lead sponsor | Novartis Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Osteoarthritis, Controlled Hypertension |
| Intervention type | Drug |
| Interventions | lumiracoxib |
| Enrollment | 1,020 |
| Start date | Nov 1, 2005 |
| Primary completion | Sep 1, 2006 |
| First posted | Dec 20, 2005 |
| Last update posted | Feb 7, 2017 |
| Countries | Germany, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: